UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

Cancer treatment reviews, 2018-07, Vol.68, p.102-110

2018

Volltextzugriff (PDF)

Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis

British journal of dermatology (1951), 2016-12, Vol.175 (6), p.1166-1174

2016

Volltextzugriff (PDF)

Oxaliplatin-based Chemotherapy: A New Option in Advanced Hepatocellular Carcinoma. A Systematic Review and Pooled Analysis

Clinical oncology (Royal College of Radiologists (Great Britain)), 2014-08, Vol.26 (8), p.488-496

2014

Volltextzugriff (PDF)

Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis

Journal of gastrointestinal cancer, 2015-09, Vol.46 (3), p.212-218

2015

Volltextzugriff (PDF)

Clinical use of immune-checkpoint inhibitors: focus on late immune-related adverse events and pseudoprogression

Annals of oncology, 2017-10, Vol.28, p.vi63-vi63

2017

Volltextzugriff (PDF)

Adherence to WHO pain guidelines in a community hospital

Annals of oncology, 2015, Vol.26, p.vi115

2015

Volltextzugriff (PDF)

Efficacy of antibiotic prophylaxis with tetracyclines for EGFR induced skin rash: a systematic review and pooled-analysis of 13 studies

Annals of oncology, 2016-09, Vol.27, p.iv108

2016

Volltextzugriff (PDF)

[PP.06.11] ANTIANGIOGENETICS AND HYPERTENSION: EPIDEMIOLOGY AND BASAL FEATURES OF PATIENTS

Journal of hypertension, 2016-09, Vol.34 (Supplement 2), p.e150

2016

Volltextzugriff (PDF)

LDH as prognostic factor for survival in castration-resistant prostate cancer (CRPC): a systematic review and pooled analysis of the literature

Annals of oncology, 2015-10, Vol.26, p.vi60

2015

Volltextzugriff (PDF)

20 years single center experience with testicular cancer

Annals of oncology, 2015-10, Vol.26, p.vi65

2015

Volltextzugriff (PDF)

Resection Rate with Folfirinox-Based Neoadjuvant Therapy in Locally Advanced/Borderline Resectable Pancreatic Cancer: a Pooled Analysis of Published Data

Annals of oncology, 2014-09, Vol.25, p.iv240

2014

Volltextzugriff (PDF)

708PRESECTION RATE WITH FOLFIRINOX-BASED NEOADJUVANT THERAPY IN LOCALLY ADVANCED/BORDERLINE RESECTABLE PANCREATIC CANCER: A POOLED ANALYSIS OF PUBLISHED DATA

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv240-iv240

2014

Volltextzugriff (PDF)

Over the years change in prostate cancer management through the multidisciplinary team at a community hospital

Annals of oncology, 2016-09, Vol.27, p.iv33

2016

Volltextzugriff (PDF)

Find yourself with a smile

Annals of oncology, 2015-10, Vol.26, p.vi131

2015

Volltextzugriff (PDF)

“Comitato ospedale senza dolore”: a successful strategy

Annals of oncology, 2015-10, Vol.26, p.vi116

2015

Volltextzugriff (PDF)

First visit is never forgotten

Annals of oncology, 2015-10, Vol.26, p.vi129

2015

Volltextzugriff (PDF)

Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration

The Annals of pharmacotherapy, 2010-05, Vol.44 (5), p.838-843

2010

Volltextzugriff (PDF)

Prognostic role of ER+ associated with other clinical and biological features in patients with T4 breast cancer achieving less than a pathological complete response (<pCR) after primary chemotherapy: 10-year results

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.e11047-e11047

2010

Volltextzugriff (PDF)

Adding cisplatin to an anthracycline-based primary chemotherapy in triple-negative (TN) and non-triple negative (non-TN) T4 breast cancer patients (pts): Long-term outcomes

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.583-583

2009

Volltextzugriff (PDF)

Outcomes in double-negative (HER2/PR negative) LABC phenotype treated with cisplatin-based primary chemotherapy: Impact of intensified regimen

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.11024-11024

2007

Volltextzugriff (PDF)

A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer

Gynecologic oncology, 2014-04, Vol.133 (1), p.117-123

2014

Volltextzugriff (PDF)

A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer

International journal of colorectal disease, 2015-04, Vol.30 (4), p.447-457

2015

Volltextzugriff (PDF)

The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis

Breast cancer research and treatment, 2014-04, Vol.144 (2), p.223-232

2014

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(94)
Tagungsberichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(55)
Science & Technology
(53)
Life Sciences & Biomedicine
(52)
Oncology
(28)
Female
(19)
Male
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Meta-Analysis
(15)
Treatment Outcome
(15)
Chemotherapy
(13)
Hematology, Oncology And Palliative Medicine
(13)
Overall Survival
(13)
Prognosis
(12)
Biological And Medical Sciences
(11)
Colorectal Cancer
(11)
Animals
(10)
Antineoplastic Agents - Therapeutic Use
(10)
Disease-Free Survival
(10)
Colorectal Neoplasms - Pathology
(9)
Medicine
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis

Oxaliplatin-based Chemotherapy: A New Option in Advanced Hepatocellular Carcinoma. A Systematic Review and Pooled Analysis

Tumour Budding and Survival in Stage II Colorectal Cancer: a Systematic Review and Pooled Analysis

Clinical use of immune-checkpoint inhibitors: focus on late immune-related adverse events and pseudoprogression

Adherence to WHO pain guidelines in a community hospital

The new Italian registry of infantile thrombosis (RITI): A reflection on its journey, challenges and pitfalls

Corrigendum: The new Italian registry of infantile thrombosis (RITI): a reflection on its journey, challenges and pitfalls

Efficacy of antibiotic prophylaxis with tetracyclines for EGFR induced skin rash: a systematic review and pooled-analysis of 13 studies

[PP.06.11] ANTIANGIOGENETICS AND HYPERTENSION: EPIDEMIOLOGY AND BASAL FEATURES OF PATIENTS

LDH as prognostic factor for survival in castration-resistant prostate cancer (CRPC): a systematic review and pooled analysis of the literature

20 years single center experience with testicular cancer

Resection Rate with Folfirinox-Based Neoadjuvant Therapy in Locally Advanced/Borderline Resectable Pancreatic Cancer: a Pooled Analysis of Published Data

708PRESECTION RATE WITH FOLFIRINOX-BASED NEOADJUVANT THERAPY IN LOCALLY ADVANCED/BORDERLINE RESECTABLE PANCREATIC CANCER: A POOLED ANALYSIS OF PUBLISHED DATA

Over the years change in prostate cancer management through the multidisciplinary team at a community hospital

Find yourself with a smile

“Comitato ospedale senza dolore”: a successful strategy

First visit is never forgotten

Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration

Prognostic role of ER+ associated with other clinical and biological features in patients with T4 breast cancer achieving less than a pathological complete response (<pCR) after primary chemotherapy: 10-year results

Adding cisplatin to an anthracycline-based primary chemotherapy in triple-negative (TN) and non-triple negative (non-TN) T4 breast cancer patients (pts): Long-term outcomes

Outcomes in double-negative (HER2/PR negative) LABC phenotype treated with cisplatin-based primary chemotherapy: Impact of intensified regimen

A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer

A systematic review and meta-analysis of adjuvant chemotherapy after neoadjuvant treatment and surgery for rectal cancer

The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis

Suchergebnisse filtern